Korro Bio, Inc.KRRONASDAQ

Revenue (LTM)

$6M

+181.5% YoY

Net Income (LTM)

$-117M

-40.3% YoY

Free Cash Flow

$-79M

Revenue CAGR (5Y)

-29.6%

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	14	0	0	2	6↑181.5%
Gross Profit	10	0	0	2	2↓7.0%
Operating Income	-84	-59↑29.8%	-85↓43.3%	-92↓8.7%	-87↑5.0%
Net Income	-85	-58↑31.5%	-81↓39.9%	-84↓3.0%	-117↓40.3%
EBITDA	-80	-56↑29.4%	-81↓43.2%	-88↓9.2%	-83↑6.0%
EPS Diluted	-4.94	-227.42↓4503.6%	-53.08↑76.7%	-9.37↑82.3%	-12.48↓33.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	80	37↓53.6%	166↑349.8%	56↓66.5%	22↓60.8%
Total Current Assets	135	57↓57.6%	173↑202.6%	132↓23.9%	82↓37.4%
Total Assets	185	74↓60.2%	222↑200.6%	226↑2.1%	114↓49.8%
Total Current Liabilities	11	9↓23.9%	19↑123.9%	15↓23.2%	12↓20.2%
Total Liabilities	55	173↑216.8%	52↓70.0%	66↑27.2%	62↓5.7%
Total Equity	131	-99↓175.7%	170↑271.6%	160↓5.6%	51↓67.9%
Total Debt	46	167↑266.2%	33↓80.1%	45↑34.8%	43↓2.9%
Net Debt	-34	130↑482.1%	-133↓202.2%	-11↑91.8%	22↑299.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-32	-54↓67.1%	-67↓25.4%	-60↑10.7%	-79↓30.8%
Capital Expenditure	-4	-5↓17.2%	-8↓50.3%	-18↓128.5%	-1↑97.1%
Free Cash Flow	-37	-59↓61.1%	-75↓27.6%	-78↓3.8%	-79↓1.4%
Stock-Based Comp	1	1↑41.3%	2↑108.9%	4↑87.4%	8↑71.6%
Net Change in Cash	44	-43↓196.0%	132↑409.3%	-114↓186.7%	-34↑70.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance